BetterScholar BetterScholar
12
Role
Title
Level Year L/R
🐜 The National Lung Screening Trial: overview and study design.
19 auth. D. Aberle, C. Berg, W. Black, T. Church, R. Fagerstrom, Barbara Galen, I. Gareen, C. Gatsonis, J. Goldin, J. Gohagan, ... B. Hillman, C. Jaffe, B. Kramer, D. Lynch, P. Marcus, M. Schnall, D. Sullivan, Dorothy Sullivan, C. Zylak
10 2011
10
🐜
🐜 Results of initial low-dose computed tomographic screening for lung cancer.
15 auth. T. Church, W. Black, D. Aberle, C. Berg, Kathy L Clingan, F. Duan, R. Fagerstrom, I. Gareen, D. Gierada, Gordon C. Jones, ... I. Mahon, P. Marcus, Jorean D. Sicks, Amanda Jain, S. Baum
9 2013
9
🐜
🐜 National Institutes of Health Consensus Development Conference Statement: management of hepatitis B.
12 auth. M. Sorrell, E. Belongia, JosΓ© Costa, I. Gareen, J. Grem, J. Inadomi, ... E. Kern, J. A. McHugh, G. Petersen, M. F. Rein, D. Strader, Hartwell T. Trotter
9 2009
9
🐜
🐜 Cost-effectiveness of CT screening in the National Lung Screening Trial.
11 auth. W. Black, I. Gareen, S. Soneji, Jorean D. Sicks, E. Keeler, D. Aberle, ... A. Naeim, T. Church, G. Silvestri, J. Gorelick, C. Gatsonis
8 2014
8
🐜
🐜 Results of the two incidence screenings in the National Lung Screening Trial.
18 auth. D. Aberle, S. DeMello, C. Berg, W. Black, B. Brewer, T. Church, Kathy L Clingan, F. Duan, R. Fagerstrom, I. Gareen, ... C. Gatsonis, D. Gierada, Amanda Jain, Gordon C. Jones, I. Mahon, P. Marcus, J. Rathmell, Jorean D. Sicks
8 2013
8
🐜
🐜 Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia
14 auth. G. Rabinovici, C. Gatsonis, Charles Apgar, K. Chaudhary, I. Gareen, Lucy Hanna, James A. Hendrix, B. Hillner, Cynthia Olson, O. Lesman-Segev, ... Justin Romanoff, B. Siegel, R. Whitmer, M. Carrillo
8 2019
8
🐜
🐜 Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET Registry.
8 auth. B. Hillner, Barry A. Siegel, Dawei Liu, A. Shields, I. Gareen, Lucy Hanna, ... S. H. Stine, R. Coleman
8 2008
8
🐜
🐜 Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae.
8 auth. J. Lonks, J. Garau, L. GΓ³mez, M. Xercavins, A. Ochoa de EchagΓΌen, I. Gareen, ... P. Reiss, A. Medeiros
8 2002
8
🐜
🐜 Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection Among Women With Dense Breasts Undergoing Screening.
17 auth. C. Comstock, C. Gatsonis, G. Newstead, B.S. Snyder, I. Gareen, Jennifer T Bergin, H. Rahbar, Janice S. Sung, Christina Jacobs, J. Harvey, ... Mary H Nicholson, R. C. Ward, Jacqueline Holt, Andrew Prather, K. Miller, M. Schnall, C. Kuhl
8 2020
8
🐜
🐜 National Institutes of Health consensus development conference statement: Management of hepatitis B
12 auth. M. Sorrell, E. Belongia, JosΓ© Costa, I. Gareen, J. Grem, J. Inadomi, ... E. Kern, J. A. McHugh, G. Petersen, M. F. Rein, D. Strader, Hartwell T. Trotter
8 2009
8
🐜
🐜 Lung Cancer Incidence and Mortality with Extended Follow-up in the National Lung Screening Trial National Lung Screening Trial Writing Team 1.
9 auth. W. Black, C. Chiles, T. Church, I. Gareen, D. Gierada, I. Mahon, ... Eric A. Miller, P. Pinsky, Jorean D. Sicks
7 2019
7
🐜
🐜 Relationship Between Cancer Type and Impact of PET and PET/CT on Intended Management: Findings of the National Oncologic PET Registry
7 auth. B. Hillner, B. Siegel, A. Shields, Dawei Liu, I. Gareen, Ed Hunt, ... R. Coleman
7 2008
7
🐜